Exposure to Hydrocarbons and Renal Disease: An Experimental Animal Model

References

• Anderson K. Acute nephritis due to turpentine absorbed by the skin. Br Med J 1912; 3: 881
   Google Scholar
• Zimmerman S W, Groheler K, Beirne G J. Hydrocarbon exposure and chronic glomerulonephritis. Lancet 1973; ii: 199–201
   Google Scholar
• Lagrue G, Kamalodine T, Hirbec G, et al. Role de l'inhalstion de substances toxiques dans la genèse des glomeruloephrites. Nouv Presse Med 1977; 6: 3609–3613
   PubMedGoogle Scholar
• Ravnskov U. Exposure to organic solvent - a missing link in poststreptococcal glomerulonephritis. Acta Med Scand 1978; 203: 351–356
   PubMedGoogle Scholar
• Ravnskov U, Forsberg B, Skerfving S. Glomerulonephritis and exposure to organic solvents. A case control study. Acta Med Scand 1979; 205: 575–579
   PubMedGoogle Scholar
• Finn R, Fennerty A G, Ahmad R. Hydrocarbon exposure and glomerulonephritis. Clin Nephrol 1980; 14: 173–175
   PubMed Web of Science ®Google Scholar
• Ravnskov U, Lundstrom S, Norden A. Hydrocarbon exposure and glomerulonephritis: evidence from patient's occupations. Lancet 1983; ii: 1214–1216
   Google Scholar
• Bell G M, Gordon A CH, Lee P, et al. Proliferative glomerulonephritis and exposure to organic solvents. Nephron 1985; 40: 161–165
   PubMed Web of Science ®Google Scholar
• Daniell W E, Couser W G, Rosenstock L. Occupational solvent exposure and glomerulonephritis. A case-report and review of the literature. JAMA 1988; 259: 2280–2283
   PubMed Web of Science ®Google Scholar
• Ravnskov U. Glomerulonephritis, renal carcinoma, and solvent exposure: bias from choice of referents. Br J Int Med 1990; 47: 791–792
   Google Scholar
• Yaqoob M, Bell G M, Percy D F, Finn R. Primary glomerulonephritis and hydrocarbon exposure: a case-control study and literature review. Q J Med 1992; 83: 409–418
   PubMedGoogle Scholar
• Porro A, Lomonte C, Coratelli P, et al. Chronic glomerulonephritis and exposure to solvents: a case-referent study. Br J Int Med 1992; 49: 738–742
   Google Scholar
• Van D Er, Laan G. Chronic glomerulonephritis and organic solvents. Int Arch Occup Environ Health 1980; 47: 1–8
   PubMedGoogle Scholar
• Harrington J M, Whitby H, Gray N C, et al. Renal disease and occupational exposure to organic solvents: a case referent approach. Br J Int Med 1989; 46: 643–650
   Google Scholar
• Mutti A, Lucertini S, Falzoi M, et al. Organic solvents and chronic glomerulonephritis: A cross-sectional study with negative findings for aliphatic and alicyclic C5-C7 hydrocarbons. J Appl Toxicol 1981; 1: 224–226
   PubMedGoogle Scholar
• Askergren A. Studies on kidney functions in subjects exposed to organic solvents: III. Excretion of cells in the urine. Acta Med Scand 1981; 210: 101–106
   Google Scholar
• Askergren A, Allgen L G, Karlsson C, et al. Studies on kidney functions in subjects exposed to organic solvents: I. Excretion of albumin and β2-microglobulin in the urine. Acta Med Scand 1981; 209: 479–483
   PubMedGoogle Scholar
• Franchini I, Cavatorta A, Falzoi M, et al. Early indicators of renal damage in workers exposed to organic solvents. Int Arch Occup Environ Health 1983; 52: 1–9
   PubMed Web of Science ®Google Scholar
• Lauwerys R, Herbrand J, Buchet J P, et al. Health surveillance of workers exposed to tetrachloroethylene in dry-cleaning shops. Int Arch Occup Environ Health 1983; 52: 69–77
   PubMed Web of Science ®Google Scholar
• Viau C, Bernard A, Lauwerys R, et al. A cross-sectional survey of kidney function in refinery workers. Am J Int Med 1987; 11: 177–187
   Google Scholar
• Hashimoto D M, Kelsey K T, Seitz T, et al. The presence of urinary cellular sediment and albuminuria in newspaper pressworkers exposed to solvents. J Occup Med 1991; 33: 516–526
   PubMedGoogle Scholar
• Hotz P, Pilliod J, Soderstrom D, et al. Relation between renal function tests and a retrospective organic solvent exposure score. Br J Int Med 1989; 46: 815–819
   Google Scholar
• Ng T P, Ong S G, Lam W K, et al. Urinary levels of proteins and metabolites in workers exposed to toluene. A cross-sectional study. Int Arch Occup Environ Health 1990; 62: 42–46
   Google Scholar
• Boogaard P J, Rocchi P S, van Sittert N J. Effects of exposure to low concentrations of chlorinated hydrocarbons on the kidney and liver of industrial workers. Br J Int Med 1993; 50: 331–339
   Google Scholar
• Yaqoob M, Bell G M, Stevenson A, et al. Renal impairment with chronic hydrocarbon exposure. Q J Med 1993; 86: 165–174
   PubMedGoogle Scholar
• Mutti A, Alinovi R, Bergamaschi E, et al. Nephropathies and exposure to perchloroethylene in dry cleaners. Lancet 1992; 340: 189–193
   PubMed Web of Science ®Google Scholar
• Zimmermann S W, Norbach D H. Nephrotoxic effects of long-term carbon tetrachloride administration in rats. Arch Pathol Lab Med 1980; 104: 94–99
   PubMedGoogle Scholar
• Easley J R, Holland J M, Gipson L C, Whittaker M J. Renal toxicity of middle distillates of shale oil and petroleum in mice. Toxicol Appl Pharmacol 1982; 65: 84–91
   PubMed Web of Science ®Google Scholar
• Phillips R D, Cockrell D VM. Effect of certain light hydrocarbons on the kidney function and structure in male rats. Renal effects of petroleum hydrocarbons, MA Mehlam, C P Hemstreet, III, J J Thorpe, N K Weaver. Princeton Scientific Publishers, Princeton 1984; 89–106
   Google Scholar
• Bergamaschi E, Mutti A, Bocchi M C, et al. Rat model of perchloroethylene-induced renal dysfunctions. Environ Res 1992; 59: 427–439
   PubMed Web of Science ®Google Scholar
• Yaqoob M, Stevenson A, Mason H, Bell G M. Hydrocarbon exposure and tubular damage: additional factors in the progression of renal failure in primary glomerulonephritis. Q J Med 1993; 86: 661–667
   PubMedGoogle Scholar
• Stengel B, Cenee S, Limasset J C, et al. Organic solvent exposure may increase the risk of glomerular nephropathies with chronic renal failure. Int J Epidemiol 1995; 24: 427–434
   PubMed Web of Science ®Google Scholar
• Okuda S, Oh Y, Tsuruda H, Onoyama K, Fujimi S, Fujishima M. Adriamycin-mduced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 1986; 29: 502–510
   PubMed Web of Science ®Google Scholar
• Coccini T, Fenoglio C, Nano R, De Piceis Polver P, Moscato G, Manzo L. Styrene induced alterations in the respiratory tract of rats treated by inhalation or intraperitoneally. J Toxicol Environ Health 1997; 52: 63–77
   PubMed Web of Science ®Google Scholar
• Alinovi R, Mutti A, Bergamaschi E, Franchini I. Competitive enzyme-linked immunosorbent assay (CELISA) of urinary albumin. Clin Chem 1988; 34: 993–996
   PubMed Web of Science ®Google Scholar
• Lucertini S, Valcavi F'P, Mutti A, Franchini I. Enzyme-linked immunosorbenl. assay of retinol-binding protein in serum and mine. Clin Chem 1984; 30: 149–151
   PubMed Web of Science ®Google Scholar
• Read S M, Northcate D M. Minimization of variation in the response of different proteins to the Coomassie-blue dye binding assay for protein. Anal Biochem 1981; 116: 53–64
   PubMed Web of Science ®Google Scholar
• Halatek T, Hermans C, Broeckaert F, et al. Quantification of Clara cell protein in rat and mouse biological fluids using a sensitive immunoassay. Eur Resp J 1998; 11: 726–733
   PubMed Web of Science ®Google Scholar
• Engvall E, Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 1977; 20: 1–5
   PubMed Web of Science ®Google Scholar
• Nonclercq D, Wrona S, Toubeau G, et al. Tubular injury and regeneration in rat kidney following acute exposure to gentamycin: atime course study. Renal Failure 1992; 14: 507–521
   PubMed Web of Science ®Google Scholar
• Khalil-Manesh F, Gonick H C, Cohen A H, et al. Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int 1992; 41: 1192–1203
   PubMed Web of Science ®Google Scholar
• Delahanty L M. Implications of the diabetes control and complications trial for renal outcomes and medical nutrition therapy. J Ren Nutr 1998; 8: 59–63
   PubMedGoogle Scholar
• Chakrabarty S, Brodeur J. The nephrotoxic potential of styrene in Sprague-Dawley rats. Toxicol Lett 1983; 18: 315–321
   PubMedGoogle Scholar
• Ladefoged O, Lam H R, Ostergaard G, et al. Toxicity of the styrene metabolite phenylglyoxylic acid in rat after three months' oral dosing. Neurotoxicology 1998; 19: 721–737
   PubMed Web of Science ®Google Scholar
• Chakrabarti S, Malick M A. In vivo nephrotoxic action of an isomeric mixture of S-(1-phenyl-2-hydroxyethyl)glutathione and S-(2-phenyl-2-hydroxyethyl)glutathione in Fischer-344 rats. Toxicology 1991; 67: 15–27
   PubMed Web of Science ®Google Scholar
• Craan A G, Malick M A. Structure-nephrotoxicity relationships of glutathione pathway intermediates derived from organic solvents. Toxicology 1989; 31: 47–61
   Google Scholar
• Viau C, Bernard A, De Russis R, Ouled A, Maldague P, Lauwerys R. Evaluation of the nephrotoxic potential of styrene in man and in rat. J Appl Toxicol 1987; 7: 313–316
   PubMed Web of Science ®Google Scholar
• Verplanke A J. Effects on the kidney of occupational exposure to styrene. Int Arch Occup Environ Health 1998; 71: 47–52
   PubMedGoogle Scholar
• Ginevri F, Trivelli A, Mutti A, et al. Progression of chronic adriamycin nephropathy in leukopenic rats. Nephron 1993; 63: 79–88
   PubMed Web of Science ®Google Scholar
• Chen A, Sheu L F, Ho Y S, et al. WH Experimental focal segmental glomerulosclerosis in mice. Nephron 1998; 78: 440–452
   PubMedGoogle Scholar
• Bergamaschi E, Smargiassi A, Mutti A, et al. Immunological changes among, workers occupationally exposed to styrene. Int Arch Occup Environ Health, 67: 165–171
   PubMedGoogle Scholar
• Bagchi D, Bagchi M, Hassoun E A, et al. Adriamycin-induced hepatic and myocardial lipid peroxidation and DNA damage, and enhanced excretion of urinary lipid metabolites in rats. Toxicology 1995; 95: 1–9
   PubMed Web of Science ®Google Scholar
• Milner L S, Wei S H, Stohs S J, et al. Role of glutathione metabolism in the reduction of proteinuria by dimethylthiourea in adriamycin nephrosis. Nephron 1992; 62: 192–197
   PubMedGoogle Scholar
• Morgan W A, Kaler B, Bach P H. The role of reactive oxygen species in adriamycin and menadione glomerular toxicity. Toxicol Lett 1998; 94: 209–215
   PubMed Web of Science ®Google Scholar
• Sumner S J, Fennell T R. Review of the metabolic fate of styrene. Cm Rev Toxicol 1994; 24: S11–S33
   PubMed Web of Science ®Google Scholar
• Lock E A. Mechanism of nephrotoxic action due to organohalogenated compounds. Toxicol Lett 1989; 46: 93–106
   PubMed Web of Science ®Google Scholar
• Tanii H, Huang J, Ohyashiki T, Hashimoto K. Physical-chemical-activity relationship of organic solvents: effects on Na(+)-K(+)-ATPase activity and membrane fluidity in mouse synaptosomes. Neurotoxicol Teratol 1994; 16: 575–582
   PubMedGoogle Scholar
• Engelke M, Diehl H, Tahti H. Effects of toluene and n-hexane on rat synaptosomal membrane fluidity and integral enzyme activities. Pharmacol Toxicol 1992; 71: 343–347
   PubMedGoogle Scholar
• Savin V J, Sharma R, Sharma M, et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med Apr 4, 1996; 334(14: 878–883
   Google Scholar
• Haas M, Godfrin Y, Oberbauer R, et al. Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis. Nephrol Dial Transplant 1998; 13: 2013–2016
   PubMed Web of Science ®Google Scholar